Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection as a Community Level Intervention in Response to a Passively Identified Index Malaria Case in Swaziland
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- 02 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2018.
- 02 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2017.
- 02 Feb 2017 Status changed from not yet recruiting to recruiting.